Contribution of serotonin type 3 receptors in the successful extinction of cued or contextual fear conditioned responses: Interactions with GABAergic signalling

Reviews in the Neurosciences

Volumn 23, Issue 5-6, 2012, Pages 555-569

  Park, Su Mi ^a   Williams, Cedric L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

5 HT receptors; Amygdala; Extinction; Fear conditioning; Granisetron

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; GEPHYRIN; GRANISETRON; SEROTONIN 3 RECEPTOR; SODIUM CHLORIDE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; EMOTION; FEAR; GABAERGIC SYSTEM; LEARNING; MALE; MEMORY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; TRAINING;

ANALYSIS OF VARIANCE; ANIMALS; CARRIER PROTEINS; CONDITIONING (PSYCHOLOGY); CUES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTINCTION, PSYCHOLOGICAL; FEAR; GENE EXPRESSION REGULATION; GRANISETRON; MALE; MEMBRANE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84869418786     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/revneuro-2012-0052     Document Type: Article

References (52)

1. Adell, A. (2010). Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety. IDrugs 13, 900-910.
2. Bannai, H., Levi, S., Schweizer, C., Inoue, T., Launey, T., Racine, V., Sibarita, J.B., Mikoshiba, K., and Triller, A. (2009). Activitydependent tuning of inhibitory neurotransmission based on GABA(A)R diffusion dynamics. Neuron. 62, 670-682.
3. Basoglu, M., Salcioglu, E., and Livanou, M. (2007). A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator RID A-1394-2008 RID B-3627-2008. Psychol. Med. 37, 203-213.
4. Betz, H. (1998). Gephyrin, a major player in GABAergic postsynaptic membrane assembly? Nat. Neurosci. 1, 541-543.
5. Blanchard, D.C. and Blanchard, R.J. (1972). Innate and conditioned reactions to threat in rats with amygdaloid lesions. J. Comp. Physiol. Psychol. 81, 281-290.
6. Buhot, H., Martin, S., and Segu, L. (2000). Role of serotonin in memory impairment. Ann. Med. 32, 210-221.
7. Carli, M., Luschi, R., and Samanin, R. (1997). Dose-related impairment of spatial learning by intrahippocampal scopolamine: antagonism by ondansetron, a 5-HT3 receptor antagonist. Behav. Brain Res. 82, 185-194.
8. Chhatwal, J., Myers, K., Ressler, K., and Davis, M. (2005). Regulation of gephyrin and GABA(A) receptor binding within the amygdala after fear acquisition and extinction. J. Neurosci. 25, 502-506.
9. Cloitre, M. (2009). Effective psychotherapies for posttraumatic stress disorder: a review and critique. CNS Spectrums 14, 32-43.
10. Devadoss, T., Pandey, D.K., Mahesh, R., and Yadav, S.K. (2010). Effect of acute and chronic treatment with QCF-3 (4-benzylpiperazin- 1-yl) (quinoxalin-2-yl) methanone, a novel 5-HT(3) receptor antagonist, in animal models of depression. Pharmacol. Rep. 62, 245-257.
11. Difede, J., Cukor, J., Jayasinghe, N., Patt, I., Jedel, S., Spielman, L., and Hoffman, H.G. (2007). Virtual reality exposure therapy for the treatment of posttraumatic stress disorder following September 11, 2001. J. Clin. Psychiatry 68, 1639-1647.
12. Eccles, S., Kim, E., and O'Hare, E. (2005). Granisetron attenuates exercise-induced conditioned taste aversion in the rat. Appetite 44, 325-328.
13. Fink, K.B. and Gothert, M. (2007). 5-HT receptor regulation of neurotransmitter release. Pharmacol. Rev. 59, 360-417.
14. Foa, E., Hembree, E., Cahill, S., Rauch, S., Riggs, D., Feeny, N., and Yadin, E. (2005). Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J. Consult. Clin. Psychol. 73, 953-964.
15. Friedman, M.J., Marmar, C.R., Baker, D.G., Sikes, C.R., and Farfel, G.M. (2007). Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J. Clin. Psychiatry 68, 711-720.
16. Gan, T.J. (2005). Selective serotonin 5-HT 3 receptor antagonists for postoperative nausea and vomiting: are they all the same? CNS Drugs 19, 225-238.
17. Hannon, J. and Hoyer, D. (2008). Molecular biology of 5-HT receptors. Behav. Brain Res. 195, 198-213.
18. Harmer, C., Reid, C., Ray, M., Goodwin, G., and Cowen, P. (2006). 5HT3 antagonism abolishes the emotion potentiated startle effect in humans. Psychopharmacology 186, 18-24.
19. Heim, C. and Nemeroff, C.B. (2009). Neurobiology of posttraumatic stress disorder. CNS Spectrums 14, 13-24.
20. Heldt, S.A. and Ressler, K.J. (2007). Training-induced changes in the expression of GABA(A)-associated genes in the amygdala after the acquisition and extinction of Pavlovian fear. Eur. J. Neurosci. 26, 3631-3644.
21. Hodges, H., Sowinski, P., Turner, J., and Fletcher, A. (1996). Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system. Psychopharmacology 125, 146-161.
22. Hong, E. and Meneses, A. (1996). Systemic injection of p-chloroamphetamine eliminates the effect of the 5-HT3 compounds on learning. Pharmacol. Biochem. Behav. 53, 765-769.
23. Jacob, T.C., Moss, S.J., and Jurd, R. (2008). GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition. Nat. Rev. Neurosci. 9, 331-343.
24. Joels, M., Pu, Z., Wiegert, O., Oitzl, M.S., and Krugers, H.J. (2006). Learning under stress: how does it work? Trends Cognit. Sci. 10, 152-158.
25. Kelley, S.P., Bratt, A.M., and Hodge, C.W. (2003). Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice. Eur. J. Pharmacol. 461, 19-25.
26. Kilpatrick, G., Jones, B., and Tyers, M. (1987). Identification and distribution of 5-HT3 receptors in rat-brain using radioligand binding. Nature 330, 746-748.
27. Laporte, A., Koscielniak, T., Ponchant, M., Verge, D., Hamon, M., and Gozlan, H. (1992). Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [I-125] iodo-zacopride and [H-3] zacopride as radioligands. Synapse 10, 271-281.
28. Lehner, M., Wislowska-Stanek, A., Skorzewska, A., Maciejak, P., Szyndler, J., Turzynska, D., and Plaznik, A. (2010). Differences in the density of GABA-A receptor alpha-2 subunits and gephyrin in brain structures of rats selected for low and high anxiety in basal and fear-stimulated conditions, in a model of contextual fear conditioning. Neurobiol. Learn. Mem. 94, 499-508.
29. Lin, H., Mao, S., and Gean, P. (2009). Block of gamma-aminobutyric acid-A receptor insertion in the amygdala impairs extinction of conditioned fear. Biol. Psychiatry 66, 665-673.
30. Luscher, B., Fuchs, T., and Kilpatrick, C.L. (2011). GABA(A) receptor trafficking-mediated plasticity of inhibitory synapses. Neuron 70, 385-409.
31. Mascagni, F. and McDonald, A. J. (2007). A novel subpopulation of 5-HT type 3A receptor subunit immunoreactive interneurons in the rat basolateral amygdala. Neuroscience 144, 1015-1024.
32. McGhee, L.L., Maani, C.V., Garza, T.H., DeSocio, P.A., Gaylord, K.M., and Black, I.H. (2009). The effect of propranolol on posttraumatic stress disorder in burned service members. J. Burn Care Res. 30, 92-97.
33. Meneses, A. (2007). Stimulation of 5-HT1A, 5-HT1B, 5-HT2A/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: short- and long-term memory. Behav. Brain Res. 184, 81-90.
34. Morales, M. and Bloom, F.E. (1997). The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon. J. Neurosci. 17, 3157-3167.
35. Morales, M. and Wang, S. (2002). Differential composition of 5-hydroxytryptamine(3) receptors synthesized in the rat CNS and peripheral nervous system. J. Neurosci. 22, 6732-6741.
36. Pei, Q., Zetterstrom, T., Leslie, R.A., and Grahame-Smith, D.G. (1993). 5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat. Eur. J. Pharmacol. 230, 63-68.
37. Pitman, R.K., Sanders, K.M., Zusman, R.M., Healy, A.R., Cheema, F., Lasko, N.B., Cahill, L., and Orr, S.P. (2002). Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol. Psychiatry 51, 189-192.
38. Pitsikas, N., Brambilla, A., and Borsini, F. (1993). DAU 6215, a novel 5-HT3 receptor antagonist, improves performance in the aged rat in the Morris water maze task. Neurobiol. Aging 14, 561-564.
39. Pratchett, L.C., Daly, K., Bierer, L.M., and Yehuda, R. (2011). New approaches to combining pharmacotherapy and psychotherapy for posttraumatic stress disorder. Expert Opin. Pharmacother. 15, 2339-2354.
40. Puig, M.V., Santana, N., Celada, P., Mengod, G., and Artigas, F. (2004). In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors. Cereb. Cortex 14, 1365-1375.
41. Rajan, K.E., Singh, H.K., Parkavi, A., and Charles, P.D. (2011). Attenuation of 1-(m-chlorophenyl)-biguanide induced hippocampus-dependent memory impairment by a standardised extract of Bacopa monnieri (BESEB CDRI-08). Neurochem. Res. 36, 2136-2144.
42. Rajkumar, R. and Mahesh, R. (2010). The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target? J. Psychopharmacol. 24, 455-469.
43. Ramamoorthy, R., Radhakrishnan, M., and Borah, M. (2008). Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models. Behav. Pharmacol. 19, 29-40.
44. Reznic, J. and Staubli, U. (1997). Effects of 5-HT3 receptor antagonism on hippocampal cellular activity in the freely moving rat. J. Neurophysiol. 77, 517-521.
45. Robb, A.S., Cueva, J.E., Sporn, J., Yang, R., and Vanderburg, D.G. (2010). Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial. J. Child Adolesc. Psychopharmacol. 20, 463-471.
46. Sassoe-Pognetto, M. and Fritschy, J. (2000). Gephyrin, a major postsynaptic protein of GABAergic synapses. Eur. J. Neurosci. 12, 2205-2210.
47. Staubli, U. and Xu, F. (1995). Effects of 5-HT3 receptor antagonism on hippocampal theta-rhythm, memory, and LTP induction in the freely moving rat. J. Neurosci. 15, 2445-2452.
48. Strawn, J.R., Keeshin, B.R., DelBello, M.P., Geracioti, T.D. Jr., and Putnam, F.W. (2010). Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: a review. J. Clin. Psychiatry 71, 932-941.
49. Sullivan, G.M. and Neria, Y. (2009). Pharmacotherapy of PTSD: current status and controversies. Psychiatr. Ann. 39, 342-347.
50. Thompson, A.J. and Lummis, S.C. (2007). The 5-HT3 receptor as a therapeutic target. Expert Opin. Ther. Targets 11, 527-540.
51. Tretter, V., Jacob, T.C., Mukherjee, J., Fritschy, J.M., Pangalos, M.N., and Moss, S.J. (2008). The clustering of GABA(A) receptor subtypes at inhibitory synapses is facilitated via the direct binding of receptor a2 subunits to gephyrin. J. Neurosci. 28, 1356-1365.
52. Walstab, J., Rappold, G., and Niesler, B. (2010). 5-HT(3) receptors: role in disease and target of drugs. Pharmacol. Ther. 128, 146-169.